.png)
Clinical Research on PWID
Clinical Research
Hiv-Aids
research using innovative technology we Scientific Federation proudly
organizing 2nd International Conference & Expo on HIV&AIDS which will
be held on September 17-18, 2018 at Toronto, Canada.
Recently the Clinical research center, they review on the
provision of a program to prevent the spread of HIV among the people who inject
drugs (PWID). The Global Prevalence of interventions to prevent the spread of the
blood-borne virus and of injecting drug among the PWID. Researchers proved that NSP (needle and
syringe programs) and OST (opioid substitution therapy) both can reduce the HIV
infection, but many of the places it was not implemented. PWID are living with
HIV in risk environment that increases health harms, most of the countries are
injecting drug use had NSP and treatment to encourage the reduction in
injecting. Scaling up of interventions for people who inject drugs remains a
crucial priority of halting the HIV, coverage of HIV prevention interventions
for PWID remains poor and insufficient. The greatest prevention benefits are
reported when both NSP and OST are implemented in high coverage in combination,
recent HIV outbreaks persistently high prevalence among people who inject drugs.
HIV-AIDS-2018 cordially invites
researchers, scientists, professors, delegates and students from all over the
world exchange information on HIV-AIDS which contains plenary sessions, keynote
speeches, poster, and oral presentations on HIV-AIDS On Emerging area on
Immunology, Microbiology, Infection&Imunnity, Public Health, Infectious
Diseases, Virology, Pathology, Psychology, Biochemistry, Epidemiology,
Gynecology, Global Health, and Population Health.
To Know More about Hiv-Aids-2018 Click Here
0 comments: